Nyheder

GeNeuro and Servier sign partnership to develop first medicine addressing a causal factor of Multiple Sclerosis 02/12/2014

New EMA recommendations for the use of CORLENTOR/PROCORALAN 21/11/2014

Intarcia and Servier sign ex-U.S. partnership for ITCA 650 in diabetes; Intarcia retains independence & full control of the U.S. & Japan 12/11/2014

Servier new research partnership with the Walter and Eliza Hall Institute to target Achilles’ heel of many cancers 02/10/2014